[HTML][HTML] CD38: an immunomodulatory molecule in inflammation and autoimmunity
ZL Piedra-Quintero, Z Wilson, P Nava… - Frontiers in …, 2020 - frontiersin.org
CD38 is a molecule that can act as an enzyme, with NAD-depleting and intracellular
signaling activity, or as a receptor with adhesive functions. CD38 can be found expressed …
signaling activity, or as a receptor with adhesive functions. CD38 can be found expressed …
NLRP3 inflammasome in neurodegenerative disease
FL Anderson, KE Biggs, BE Rankin, MC Havrda - Translational Research, 2023 - Elsevier
Neurodegenerative diseases are characterized by a dysregulated neuro-glial
microenvironment, culminating in functional deficits resulting from neuronal cell death …
microenvironment, culminating in functional deficits resulting from neuronal cell death …
PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)
While neuroinflammation is an evolving concept and the cells involved and their functions
are being defined, microglia are understood to be a key cellular mediator of brain injury and …
are being defined, microglia are understood to be a key cellular mediator of brain injury and …
Neuroinflammation creates an immune regulatory niche at the meningeal lymphatic vasculature near the cribriform plate
Meningeal lymphatics near the cribriform plate undergo lymphangiogenesis during
neuroinflammation to drain excess fluid. Here, we hypothesized that lymphangiogenic …
neuroinflammation to drain excess fluid. Here, we hypothesized that lymphangiogenic …
PET imaging of TREM1 identifies CNS-infiltrating myeloid cells in a mouse model of multiple sclerosis
Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous
system (CNS) that causes substantial morbidity and diminished quality of life. Evidence …
system (CNS) that causes substantial morbidity and diminished quality of life. Evidence …
[HTML][HTML] Emerging roles for IL-11 in inflammatory diseases
Abstract Interleukin-11 (IL-11) is a cytokine that has been strongly implicated in the
pathogenesis of fibrotic diseases and solid malignancies. Elevated IL-11 expression is also …
pathogenesis of fibrotic diseases and solid malignancies. Elevated IL-11 expression is also …
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis
Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease
characterized by myelin damage followed by axonal and ultimately neuronal loss. The …
characterized by myelin damage followed by axonal and ultimately neuronal loss. The …
Cytokine signaling in multiple sclerosis: Lost in translation
K Göbel, T Ruck, SG Meuth - Multiple Sclerosis Journal, 2018 - journals.sagepub.com
Multiple sclerosis (MS) is a common neurological disorder of putative autoimmune origin.
Clinical studies delineate abnormal expression of specific cytokines over the course of …
Clinical studies delineate abnormal expression of specific cytokines over the course of …
[HTML][HTML] OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis
A Sánchez-Fernández, DB Skouras… - Frontiers in …, 2019 - frontiersin.org
IL-1β and IL-18 are pro-inflammatory cytokines that are linked to inflammation. Activation of
the NOD-like receptor protein 3 (NLRP3) inflammasome is involved in the maturation and …
the NOD-like receptor protein 3 (NLRP3) inflammasome is involved in the maturation and …
[HTML][HTML] Interferons and multiple sclerosis: Lessons from 25 years of clinical and real-world experience with intramuscular interferon beta-1a (Avonex)
SL Cohan, BA Hendin, AT Reder, K Smoot, R Avila… - CNS drugs, 2021 - Springer
Abstract Recombinant interferon (IFN) β-1b was approved by the US Food and Drug
Administration as the first disease-modifying therapy (DMT) for multiple sclerosis (MS) in …
Administration as the first disease-modifying therapy (DMT) for multiple sclerosis (MS) in …